Long-term plasmapheresis therapy in the management of focal segmental glomerulosclerosis recurrence after kidney transplantation
The recurrence of primary focal segmental glomerulosclerosis (FSGS) after kidney transplantation (KT) appears in 30 % of the recipients. Sometimes it can cause the loss of the allograft. Although many treatments for this condition have been reported, 20 %–40 % of the affected patients are refractory...
Gespeichert in:
| Veröffentlicht in: | Transfusion and apheresis science 2021-04, Vol.60 (2), p.103046-103046, Article 103046 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 103046 |
|---|---|
| container_issue | 2 |
| container_start_page | 103046 |
| container_title | Transfusion and apheresis science |
| container_volume | 60 |
| creator | Ramirez-Guerrero, Gonzalo Sevillano Prieto, Angel M Jara-Vilugrón, Fernando Polanco Fernandez, Natalia Gonzalez Monte, Esther Henandez Vicente, Ana Rodriguez Gayo, Lucia C Praga Terente, Manuel Andrés Belmonte, Amado |
| description | The recurrence of primary focal segmental glomerulosclerosis (FSGS) after kidney transplantation (KT) appears in 30 % of the recipients. Sometimes it can cause the loss of the allograft. Although many treatments for this condition have been reported, 20 %–40 % of the affected patients are refractory or presents frequents relapses. In this paper we describe the evolution of three recipients treated with long-term plasmapheresis therapy after a recurrence of FSGS with a bad or incomplete response to other treatments. Although our findings require confirmation, long-term plasmapheresis could be a therapeutic option for this condition. |
| doi_str_mv | 10.1016/j.transci.2020.103046 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2478780179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473050220303797</els_id><sourcerecordid>2478780179</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-7549852b811279df638212aca01d75db6106126ba04ab4338ff86406333505373</originalsourceid><addsrcrecordid>eNqFkEtv2zAQhImiRZ04_QkpeOxFDh_iQ6ciMNI2gIFckjNBUSuXriSqpBTAt_70UrGTa04cEDM7ux9C15RsKKHy5rCZoh2S8xtG2PLHSSk_oAuqlS6o1Pxj1qXiBRGErdBlSgdCqKKV_IxWnJdCaFVdoH-7MOyLCWKPx86m3o6_IULyCU9Z2PGI_bBI3NvB7qGHYcKhxW1wtsMJ9stHVvsu9BDnLiTXQQxLPoKbY4TBAbZtLsB_fDPAEb-snbtybvJhuEKfWtsl-HJ-1-jpx93j9lexe_h5v73dFY5LMRVKlJUWrNaUMlU1reSaUWadJbRRoqklJZIyWVtS2rrkXLetliWRnHNBBFd8jb6d5o4x_J0hTab3yUGXF4EwJ8NKlcllQlW2ipPV5UtShNaM0fc2Hg0lZoFvDuYM3yzwzQl-zn09V8x1D81b6pV2Nnw_GSAf-uwhmjxiIdT4TGsyTfDvVPwHv4WaZg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2478780179</pqid></control><display><type>article</type><title>Long-term plasmapheresis therapy in the management of focal segmental glomerulosclerosis recurrence after kidney transplantation</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Ramirez-Guerrero, Gonzalo ; Sevillano Prieto, Angel M ; Jara-Vilugrón, Fernando ; Polanco Fernandez, Natalia ; Gonzalez Monte, Esther ; Henandez Vicente, Ana ; Rodriguez Gayo, Lucia C ; Praga Terente, Manuel ; Andrés Belmonte, Amado</creator><creatorcontrib>Ramirez-Guerrero, Gonzalo ; Sevillano Prieto, Angel M ; Jara-Vilugrón, Fernando ; Polanco Fernandez, Natalia ; Gonzalez Monte, Esther ; Henandez Vicente, Ana ; Rodriguez Gayo, Lucia C ; Praga Terente, Manuel ; Andrés Belmonte, Amado</creatorcontrib><description>The recurrence of primary focal segmental glomerulosclerosis (FSGS) after kidney transplantation (KT) appears in 30 % of the recipients. Sometimes it can cause the loss of the allograft. Although many treatments for this condition have been reported, 20 %–40 % of the affected patients are refractory or presents frequents relapses. In this paper we describe the evolution of three recipients treated with long-term plasmapheresis therapy after a recurrence of FSGS with a bad or incomplete response to other treatments. Although our findings require confirmation, long-term plasmapheresis could be a therapeutic option for this condition.</description><identifier>ISSN: 1473-0502</identifier><identifier>EISSN: 1878-1683</identifier><identifier>DOI: 10.1016/j.transci.2020.103046</identifier><identifier>PMID: 33455879</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Focal segmental glomerulosclerosis ; Health technology assessment ; Kidney transplantation ; Plasmapheresis</subject><ispartof>Transfusion and apheresis science, 2021-04, Vol.60 (2), p.103046-103046, Article 103046</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-7549852b811279df638212aca01d75db6106126ba04ab4338ff86406333505373</citedby><cites>FETCH-LOGICAL-c365t-7549852b811279df638212aca01d75db6106126ba04ab4338ff86406333505373</cites><orcidid>0000-0001-8803-355X ; 0000-0002-1696-9997 ; 0000-0003-0291-6680 ; 0000-0003-0238-1364</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1473050220303797$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33455879$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramirez-Guerrero, Gonzalo</creatorcontrib><creatorcontrib>Sevillano Prieto, Angel M</creatorcontrib><creatorcontrib>Jara-Vilugrón, Fernando</creatorcontrib><creatorcontrib>Polanco Fernandez, Natalia</creatorcontrib><creatorcontrib>Gonzalez Monte, Esther</creatorcontrib><creatorcontrib>Henandez Vicente, Ana</creatorcontrib><creatorcontrib>Rodriguez Gayo, Lucia C</creatorcontrib><creatorcontrib>Praga Terente, Manuel</creatorcontrib><creatorcontrib>Andrés Belmonte, Amado</creatorcontrib><title>Long-term plasmapheresis therapy in the management of focal segmental glomerulosclerosis recurrence after kidney transplantation</title><title>Transfusion and apheresis science</title><addtitle>Transfus Apher Sci</addtitle><description>The recurrence of primary focal segmental glomerulosclerosis (FSGS) after kidney transplantation (KT) appears in 30 % of the recipients. Sometimes it can cause the loss of the allograft. Although many treatments for this condition have been reported, 20 %–40 % of the affected patients are refractory or presents frequents relapses. In this paper we describe the evolution of three recipients treated with long-term plasmapheresis therapy after a recurrence of FSGS with a bad or incomplete response to other treatments. Although our findings require confirmation, long-term plasmapheresis could be a therapeutic option for this condition.</description><subject>Focal segmental glomerulosclerosis</subject><subject>Health technology assessment</subject><subject>Kidney transplantation</subject><subject>Plasmapheresis</subject><issn>1473-0502</issn><issn>1878-1683</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkEtv2zAQhImiRZ04_QkpeOxFDh_iQ6ciMNI2gIFckjNBUSuXriSqpBTAt_70UrGTa04cEDM7ux9C15RsKKHy5rCZoh2S8xtG2PLHSSk_oAuqlS6o1Pxj1qXiBRGErdBlSgdCqKKV_IxWnJdCaFVdoH-7MOyLCWKPx86m3o6_IULyCU9Z2PGI_bBI3NvB7qGHYcKhxW1wtsMJ9stHVvsu9BDnLiTXQQxLPoKbY4TBAbZtLsB_fDPAEb-snbtybvJhuEKfWtsl-HJ-1-jpx93j9lexe_h5v73dFY5LMRVKlJUWrNaUMlU1reSaUWadJbRRoqklJZIyWVtS2rrkXLetliWRnHNBBFd8jb6d5o4x_J0hTab3yUGXF4EwJ8NKlcllQlW2ipPV5UtShNaM0fc2Hg0lZoFvDuYM3yzwzQl-zn09V8x1D81b6pV2Nnw_GSAf-uwhmjxiIdT4TGsyTfDvVPwHv4WaZg</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>Ramirez-Guerrero, Gonzalo</creator><creator>Sevillano Prieto, Angel M</creator><creator>Jara-Vilugrón, Fernando</creator><creator>Polanco Fernandez, Natalia</creator><creator>Gonzalez Monte, Esther</creator><creator>Henandez Vicente, Ana</creator><creator>Rodriguez Gayo, Lucia C</creator><creator>Praga Terente, Manuel</creator><creator>Andrés Belmonte, Amado</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8803-355X</orcidid><orcidid>https://orcid.org/0000-0002-1696-9997</orcidid><orcidid>https://orcid.org/0000-0003-0291-6680</orcidid><orcidid>https://orcid.org/0000-0003-0238-1364</orcidid></search><sort><creationdate>202104</creationdate><title>Long-term plasmapheresis therapy in the management of focal segmental glomerulosclerosis recurrence after kidney transplantation</title><author>Ramirez-Guerrero, Gonzalo ; Sevillano Prieto, Angel M ; Jara-Vilugrón, Fernando ; Polanco Fernandez, Natalia ; Gonzalez Monte, Esther ; Henandez Vicente, Ana ; Rodriguez Gayo, Lucia C ; Praga Terente, Manuel ; Andrés Belmonte, Amado</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-7549852b811279df638212aca01d75db6106126ba04ab4338ff86406333505373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Focal segmental glomerulosclerosis</topic><topic>Health technology assessment</topic><topic>Kidney transplantation</topic><topic>Plasmapheresis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramirez-Guerrero, Gonzalo</creatorcontrib><creatorcontrib>Sevillano Prieto, Angel M</creatorcontrib><creatorcontrib>Jara-Vilugrón, Fernando</creatorcontrib><creatorcontrib>Polanco Fernandez, Natalia</creatorcontrib><creatorcontrib>Gonzalez Monte, Esther</creatorcontrib><creatorcontrib>Henandez Vicente, Ana</creatorcontrib><creatorcontrib>Rodriguez Gayo, Lucia C</creatorcontrib><creatorcontrib>Praga Terente, Manuel</creatorcontrib><creatorcontrib>Andrés Belmonte, Amado</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transfusion and apheresis science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramirez-Guerrero, Gonzalo</au><au>Sevillano Prieto, Angel M</au><au>Jara-Vilugrón, Fernando</au><au>Polanco Fernandez, Natalia</au><au>Gonzalez Monte, Esther</au><au>Henandez Vicente, Ana</au><au>Rodriguez Gayo, Lucia C</au><au>Praga Terente, Manuel</au><au>Andrés Belmonte, Amado</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term plasmapheresis therapy in the management of focal segmental glomerulosclerosis recurrence after kidney transplantation</atitle><jtitle>Transfusion and apheresis science</jtitle><addtitle>Transfus Apher Sci</addtitle><date>2021-04</date><risdate>2021</risdate><volume>60</volume><issue>2</issue><spage>103046</spage><epage>103046</epage><pages>103046-103046</pages><artnum>103046</artnum><issn>1473-0502</issn><eissn>1878-1683</eissn><abstract>The recurrence of primary focal segmental glomerulosclerosis (FSGS) after kidney transplantation (KT) appears in 30 % of the recipients. Sometimes it can cause the loss of the allograft. Although many treatments for this condition have been reported, 20 %–40 % of the affected patients are refractory or presents frequents relapses. In this paper we describe the evolution of three recipients treated with long-term plasmapheresis therapy after a recurrence of FSGS with a bad or incomplete response to other treatments. Although our findings require confirmation, long-term plasmapheresis could be a therapeutic option for this condition.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33455879</pmid><doi>10.1016/j.transci.2020.103046</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-8803-355X</orcidid><orcidid>https://orcid.org/0000-0002-1696-9997</orcidid><orcidid>https://orcid.org/0000-0003-0291-6680</orcidid><orcidid>https://orcid.org/0000-0003-0238-1364</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1473-0502 |
| ispartof | Transfusion and apheresis science, 2021-04, Vol.60 (2), p.103046-103046, Article 103046 |
| issn | 1473-0502 1878-1683 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2478780179 |
| source | Elsevier ScienceDirect Journals Complete |
| subjects | Focal segmental glomerulosclerosis Health technology assessment Kidney transplantation Plasmapheresis |
| title | Long-term plasmapheresis therapy in the management of focal segmental glomerulosclerosis recurrence after kidney transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T05%3A21%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20plasmapheresis%20therapy%20in%20the%20management%20of%20focal%20segmental%20glomerulosclerosis%20recurrence%20after%20kidney%20transplantation&rft.jtitle=Transfusion%20and%20apheresis%20science&rft.au=Ramirez-Guerrero,%20Gonzalo&rft.date=2021-04&rft.volume=60&rft.issue=2&rft.spage=103046&rft.epage=103046&rft.pages=103046-103046&rft.artnum=103046&rft.issn=1473-0502&rft.eissn=1878-1683&rft_id=info:doi/10.1016/j.transci.2020.103046&rft_dat=%3Cproquest_cross%3E2478780179%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2478780179&rft_id=info:pmid/33455879&rft_els_id=S1473050220303797&rfr_iscdi=true |